Conditions : Rheumatoid Arthritis; Psoriatic Arthritis; Other Rheumatic Conditions Intervention : Sponsors : The Consortium of Rheumatology Researchers of North America, Inc.; University of Massachuse...

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of ISIS CRP Rx and its effects on CRP and other pharmacodynamic measures, versus placebo, in subjects with activ...

The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of ISIS CRP Rx and its effects on CRP and other pharmacodynamic measures, versus placebo, in subjects with activ...

Condition : Rheumatoid Arthritis Intervention : Drug: Teriparatide Sponsors : Brigham and Women's Hospital; Eli Lilly and Company Not yet recruiting - verified July 2011

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo Sponsor : Hoffmann-La Roche Recruiting - verified November...

Conditions : Rheumatoid Arthritis; Lupus Erythematosus, Systemic; Sjogren's Syndrome Intervention : Sponsors : National Institutes of Health Clinical Center (CC); National Institute of Environmental H...

Conditions : Rheumatoid Arthritis; Lupus Erythematosus, Systemic; Sjogren's Syndrome Intervention : Sponsors : National Institutes of Health Clinical Center (CC); National Institute of Environmental H...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo Sponsor : Hoffmann-La Roche Active, not recruiting - verif...

Conditions : Rheumatoid Arthritis; Lupus Erythematosus, Systemic; Sjogren's Syndrome Intervention : Sponsors : National Institutes of Health Clinical Center (CC); National Institute of Environmental H...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: methotrexate; Drug: methotrexate; Drug: placebo Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting...